Environmental factors and risk for endometrial cancer development

Getting to know the most important environmental risk factors for endometrial cancer development lets us provide well programmed primary preventive activity, thus avoiding or greatly reducing environmental risk factors for diseases. This activity may lead to a reduced number of new cases of endometrial cancer. We can help women live longer and better by well programmed preventive activity even when medical knowledge has reached such a high level of development. The authors analysed environmental risk factors for endometrial cancer development based on international medical references. The aim of our work was to review the environmental risk factors for endometrial cancer development which provoke initiation of the disease, sometimes change the clinical stage of the disease and influence medical treatment.

Endometrial cancer; Risk factors; Cancer development

[I] Di Saia P. J., Creasman W. T.: "Gynaecological Oncology. Endometrial cancer". Czelej, Lublin, 1999, 137.

[2] Sturgeon S. R., Sherman M.E., Kurman R. J.: "Analysis of histopathological features of endometrioid uterine carcinomas and epidemiologic risk factors". Cancer Epid. Biomarkers Prev., 1998, 7, 231.

[3] Schottenfeld D:: "EpidemioIogy of endometrial neoplasia. Review". J. Cell B(oche_m. (suppl.), 1995, 23, 151.

[4] Parslov M.,L idegaard 0.,K lintorp S.: "Risk factors among young women with endometrial cancer: a Danish case-control study" Am. J. Obstet. Gynecol., 2000, 182, 23.

[5] Schneider D., Halperin R., Langer R. et al.: "Well-differentiated versus less-differentiated endometrial carcinoma". Eur. J. Gynaecol. Oncol., 1998, 19, 242.

[6] Shoff S. M.,N ewcomb P.A.: "Diabetes,b ody size,a nd risk of endometrial cancer". Am. J. Epidemiol.,1998,148, 234.

[7] Weiderpass E.,P ersson I.,A dami H. 0. et al.: "Body size in different periods of life,d iabetes mellitus,h ypertension,a nd risk of postmenopausal endometrial cancer (Sweden)". Cancer Causes Control., 2000, 11, 185.

[8] Swansson C. A., Potischman N., Wilbanks G. D. et al.: "Relationship of endometrial cancer risk to past and contemporary body size and body fat distribution". Cancer Epid. Biomarkers Prev., 1993, 2, 321.

[9] Carroll K. K.: "Obesity as a risk factor for certain types of cancer. Review". Lipids, 1998, 33, 1055.

[10] Goodman M. T., Hankin J. H., Wilkens L. R.: "Diet，body size, physical activity, and the risk of endometrial cancer". Cancer Res., 1997, 57, 5077.

[11] Madigan M. P., Troisi R., Potischman N.: "Serum hormone levels in relation to reproductive and lifestyle factors in postmenopausal women (United States)". Cancer Causes Control., 1998, 9, 199.

[12] Duchi T., Ijun H., Nakamura S. et al.: "Correlation of body fat distribution with grade of endometrial cancer". Gynecol. Oneal., 1997, 65, 138.

[13] Hargreaves M. K., Buchowski M. S., Hardy R. E.: "Dietary factors and cancers of breast, endometrium, and ovary: strategies for modifying fat intake in African American women. Review".A m. 1. Obstet. Gynec.,1997, 176, 255.

[14] Terry P., Baron J. A., Weiderpass E.: "Lifestyle and endometrial cancer risk: a cohort study from the Swedish Twin Registry". Int. J. Cancer, 1999, 82, 38.

[ 15] Tzonou A., Lipworth L., Kai and心A.: "Dietary factors and the risk of endometrial cancer: a case-control study in Greece". Br. J. Cancer, 1996, 73, 1284.

[16] Moradi T., Nyren 0., Bergstrom R.: "Risk for endometrial cancer in relation to occupational physical activity: a nationwide cohort study in Sweden". Int. 1. Cancer, 1998, 76, 665.

[17] Potischman N., Swanson C. A., Brinton L. A.: "Dietary associations in a case-control study of endometrial cancer". Cancer Causes Control., 1993, 4, 239.

[ 18] Levi F., Franeschi S., Negri E. et al.: "Dietary factors and risk of endometrial cancer". Cancer, 1993, 71, 3775.

[ 19] Goodman M. T., Wilkens L. R., Hankin J. H.: "Association of soy and fiber consumption with the risk of endometrial cancer". Am. J. Epidemiol., 1997, 146, 294.

[20] Negri E., La Vecchia C., Franceschi S. et al.: "Intake of selected micronutrients and the risk of endometrial carcinoma". Cancer, 1966, 77,917.

[21] Parazzini F., La Vecchia C., Negri E. et al.: "Diabetes and endometrial cancer: an Italian case-control study". Int. J. Cancer, 1999, 81,539.

[22] Siiteri P. K.: "Steroid hormones and endometrial cancer". Cancer Res., 1978, 38, 4360.

[23] Sherman M. E.: "Theories of endometrial carcinogenesis: a multidisciplinary approach. Review". Modern Pathol., 2000, 13, 295.

[24] Henderson B. E., Feigelson H. S.:'"Hormonal carcinogenesis. Review". Carcinogenesis, 2000, 27, 427.

[25] Nason F. G., Nelson B. E.: "Estrogen and progesterone in breast and gynecologic cancers. Etiology, therapeutic role, and hormone replacement. Review". Obstetrics & Gynecol. Clin. No. Am., 1994, 21, 245.

[26] Shields T. S., Weiss N. S., Voigt L. F. et al.: "The eddomeonal risk of endometrial cancer associated with unopposed estrogen use in women with other risk factors". Epidemiology, 1999, 10, 733.

[27] Weiss N. S., Farevall V. T., Szekely D. R. et al.: "Oestrogens and endometrial cancer: effect of other risk factors on the associalion". Maturitas, 1980, 2, 185.

[28] The Cancer and Sterioid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development: "Combination oral contraceptive use and the risk of endometrial cancer". J.A.M.A., 1987, 257, 796.

[29] Robinson E., Kimrnick G. G., Muss H.B.:'Tamoxifen in postmenopausal women: a safety perspective". Drugs Aging, 1996, 8, 329.

[30] Barakat R. R., Wong G., Curtin J.P. et al.: "Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features". Gynecol. Oncol., 1994, 55, 164

[31] Lobo R. A., Carmina E.: "The importance of diagnosing the polycystic ovary syndrome". Ann. Intern. Med., 2000, 132, 989.

[32] Solomon C. G.: "T he epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks". Endocrinol. Metab. Clin. No. Am., 1999, 28, 247.

[33] Duggan B. D., Dubeau L.: "Genetics and biology of gynecologic cancer. Review". Cur. Opin. Oneal., 1998, 10, 439.

[34] Meirow D., Schenker J. G.: "The link between female infertility and cancer: epidemiology and possible aetiologies. Review" Human. Reprod. Update, 1996, 2, 63.

[35] McPherson C. P., Sellers T. A., Potter J. D.: "Reproductive factors and risk of endometrial cancer. The Iowa Women's Health Study".Am. 1. Epidemiol., 1996, 143, 1195.

[36] Austin H., Drews C., Partridge E. E.: "A case-control study of endometrial cancer in relation to cigarette smoking, serum estrogen levels, and alcohol use". Am. J. Obstet. Gynecol., 1993, 169, 1086.

[37] Brinton L. A., Barrett R. J., Berman M. L.: "Cigarette smo灼ng and the risk of endometrial cancer". Am. J. Epidemiol., 1993, 137, 281.

[38] Parazzini F., La Vecchia C., Moroni S.: "Intrauterine devices use and risk of endometrial cancer". Br. J. Cancer, 1994, 70., 672.

[39] Canavan T. P., Doshi N. R.: "Endometrial cancer".Am. Fam. Physician, 2000, 61, 1280.

[40] Zatoriski W., Tyczyriski J.: "Malignant neoplasms in Poland - 1996". Centrum Onkologii - Instytut M. Sklodowskiej - Curie Zaklad Epidemiologii i Prewencji Nowotwor6w. Krajowy Rejestr. Nowotwor6w. Warszawa 1999.

[41] Patsner B.: "Endometrial cancer in women 45 years of age or younger". Eur. 1. Gynaecol. Oneal., 2000, 27, 3, 249.

[42] Gaducci A., Genazzoni A.: "Steroid hormones in endometrial and breast cancer. Review". Eur. 1. Gynaecol. Oneal., 1997, 18, 5, 371.

[43] Zarbo G., Caruso G., Zammitti M. et al.: "The effects of tamoxifen therapy on the endometrium". Eur. 1. Gynaecol. Oncol., 2000, 21, 1, 86.